TENET HEALTHCARE CORP
For the period ended May 22, 2025. Filed Apr 11, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 22, 2025 · Filed Apr 11, 2025
THC$283.33-1.1%Stored close · as of Nov 6, 2026
Contents
2024 Compensation Program Highlights
| 2024 Annual Incentive Plan Payouts | In February 2025, the HR Committee approved final payouts under our 2024 Annual Incentive Plan, with corporate performance achieved at 200% of target. Final payouts for our NEOs ranged from 220% to 300% of target payout levels after application of each officer’s individual performance multiplier. |
|---|---|
| 2024 LTI Program Awards | In February 2024, the HR Committee approved 2024 Long-Term Incentive (LTI) awards for executive officers comprised of the following RSUs: • 50% time-based awards vesting ratably over three years (40% for Dr. Sutaria); and • 50% performance-based awards earned over a three-year period based on the achievement of Adjusted EPS* and Adjusted Free Cash Flow* minus cash distributions paid to noncontrolling interests (“NCI”) (Adjusted FCF Less NCI) (60% for Dr. Sutaria). These performance metrics are established at the start of each year of the three-year performance period subject to a cumulative three-year relative total shareholder return (“Relative TSR”) performance multiplier. |
| 2022 Performance Based RSUs | In February 2025, the HR Committee certified final achievement of the 2022 performance-based RSUs granted to the NEOs, with such awards earned at 199.7% of target as a result of exceeding the target Adjusted EPS goal for 2022, below threshold achievement for the Adjusted FCF Less NCI goal for 2022, exceeding the maximum target for each applicable performance goal for 2023 and 2024, and cumulative Relative TSR ranking first against three direct competitors, resulting in application of the +25% multiplier. |
| * | See Appendix A for definitions of Adjusted EPS and Adjusted Free Cash Flow; cash distributions paid to NCI are as reflected on the Company’s consolidated statements of cash flows. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.